Expression of Thioredoxins and Glutaredoxins in Human Hepatocellular Carcinoma: Correlation to Cell Proliferation, Tumor Size and Metabolic Syndrome
- 1 April 2014
- journal article
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 27 (2) , 169-183
Abstract
Thioredoxins (Trx) and glutaredoxins (Grx) are thiol oxidoreductases that are ubiquitously expressed, and are involved in several biological processes. The expression of thioredoxins and glutaredoxins is induced in many neoplasms, and correlates with prognosis in gallbladder and colorectal carcinoma. The aim of the present study was to examine the expression pattern of these proteins (redoxins) in hepatocellular carcinoma (HCC) and to correlate their levels with clinical features. Paraffin-embedded tissues from 25 patients resected for HCC and 15 patients resected for colorectal carcinoma (CRC) liver metastases were analyzed with immunohistochemistry. Our results showed that Trx1, Trx2 and Grx5 were upregulated in HCCs as compared to the respective surrounding liver. In comparison, almost all redoxins were upregulated in CRC liver metastases, with Trx1 and Grx3 being significantly more increased in the CRC liver metastases than in the primary HCC tumors. In HCC, Trx1 correlated significantly with cell proliferation, and with a trend towards increased levels with micro-vascular invasion, while expression of Trx2 decreased with tumor size. Trx1 levels were lower in tumors of males, smokers, and patients with high alcohol consumption. Grx2 levels were significantly higher in patients with metabolic syndrome. In conclusion, this study illustrates specific correlations of individual redoxins to clinical features of HCC, and implicates the redoxins in the pathogenesis of HCC.Keywords
This publication has 26 references indexed in Scilit:
- Cellular and molecular mechanisms of hepatocellular carcinoma: an updateArchives of Toxicology, 2012
- Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinomaHPB, 2012
- Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrenceWorld Journal of Gastroenterology, 2012
- Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongueOral Oncology, 2011
- Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancerHuman Pathology, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Glutaredoxins: Glutathione-Dependent Redox Enzymes with Functions Far Beyond a Simple Thioredoxin Backup SystemAntioxidants & Redox Signaling, 2004
- The role of the redox protein thioredoxin in cell growth and cancerFree Radical Biology and Medicine, 2000
- Thioredoxin, a putative oncogene product,is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survivalHuman Pathology, 2000